Abbott Laboratories (ABT)
USD 121.13
(-2.66%)
USD 121.13
(-2.66%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 8.97 Billion USD | 14.59% |
| 2022 | 7.83 Billion USD | -14.91% |
| 2021 | 9.2 Billion USD | -28.13% |
| 2020 | 12.81 Billion USD | -14.79% |
| 2019 | 15.03 Billion USD | -4.38% |
| 2018 | 15.72 Billion USD | -15.09% |
| 2017 | 18.51 Billion USD | 446.87% |
| 2016 | 3.38 Billion USD | -15.35% |
| 2015 | 4 Billion USD | 5.76% |
| 2014 | 3.78 Billion USD | 22.55% |
| 2013 | 3.08 Billion USD | -68.1% |
| 2012 | 9.67 Billion USD | 12.46% |
| 2011 | 8.6 Billion USD | -43.67% |
| 2010 | 15.26 Billion USD | 99.7% |
| 2009 | 7.64 Billion USD | 4.27% |
| 2008 | 7.33 Billion USD | -24.84% |
| 2007 | 9.75 Billion USD | -17.93% |
| 2006 | 11.88 Billion USD | 217.92% |
| 2005 | 3.73 Billion USD | -32.68% |
| 2004 | 5.55 Billion USD | 11.22% |
| 2003 | 4.99 Billion USD | -12.65% |
| 2002 | 5.71 Billion USD | -13.77% |
| 2001 | 6.63 Billion USD | 933.57% |
| 2000 | 641.6 Million USD | -60.52% |
| 1999 | 1.62 Billion USD | -41.77% |
| 1998 | 2.79 Billion USD | 12.1% |
| 1997 | 2.48 Billion USD | 12.82% |
| 1996 | 2.2 Billion USD | 83.28% |
| 1995 | 1.2 Billion USD | 56.48% |
| 1994 | 769.32 Million USD | -9.47% |
| 1993 | 849.75 Million USD | -6.59% |
| 1992 | 909.7 Million USD | 49.38% |
| 1991 | 609 Million USD | -20.35% |
| 1990 | 764.6 Million USD | 76.34% |
| 1989 | 433.6 Million USD | 66.77% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q3 | - USD | -4.45% |
| 2024 Q1 | 8.3 Billion USD | -7.52% |
| 2024 Q2 | 7.76 Billion USD | -6.44% |
| 2023 Q1 | 6.89 Billion USD | -12.04% |
| 2023 Q3 | 8.81 Billion USD | -2.13% |
| 2023 Q2 | 9.01 Billion USD | 30.76% |
| 2023 FY | 8.97 Billion USD | 14.59% |
| 2023 Q4 | 8.97 Billion USD | 1.79% |
| 2022 Q4 | 7.83 Billion USD | 14.87% |
| 2022 Q3 | 6.82 Billion USD | -12.82% |
| 2022 Q2 | 7.82 Billion USD | -16.91% |
| 2022 Q1 | 9.41 Billion USD | 2.26% |
| 2022 FY | 7.83 Billion USD | -14.91% |
| 2021 Q2 | 9.84 Billion USD | -5.26% |
| 2021 Q1 | 10.39 Billion USD | -18.9% |
| 2021 Q3 | 9.09 Billion USD | -7.6% |
| 2021 Q4 | 9.2 Billion USD | 1.23% |
| 2021 FY | 9.2 Billion USD | -28.13% |
| 2020 Q3 | 14.08 Billion USD | -5.58% |
| 2020 FY | 12.81 Billion USD | -14.79% |
| 2020 Q4 | 12.81 Billion USD | -9.03% |
| 2020 Q1 | 14.89 Billion USD | -0.92% |
| 2020 Q2 | 14.91 Billion USD | 0.14% |
| 2019 FY | 15.03 Billion USD | -4.38% |
| 2019 Q1 | 16.03 Billion USD | 1.97% |
| 2019 Q2 | 16.05 Billion USD | 0.16% |
| 2019 Q3 | 15 Billion USD | -6.55% |
| 2019 Q4 | 15.03 Billion USD | 0.19% |
| 2018 Q4 | 15.72 Billion USD | -2.88% |
| 2018 Q3 | 16.18 Billion USD | -8.04% |
| 2018 Q2 | 17.6 Billion USD | -2.38% |
| 2018 Q1 | 18.03 Billion USD | -2.61% |
| 2018 FY | 15.72 Billion USD | -15.09% |
| 2017 Q1 | 15.26 Billion USD | 350.92% |
| 2017 FY | 18.51 Billion USD | 446.87% |
| 2017 Q4 | 18.51 Billion USD | 42.3% |
| 2017 Q3 | 13.01 Billion USD | -9.35% |
| 2017 Q2 | 14.35 Billion USD | -5.97% |
| 2016 Q2 | 6.33 Billion USD | 20.51% |
| 2016 Q1 | 5.25 Billion USD | 31.4% |
| 2016 Q4 | 3.38 Billion USD | -43.66% |
| 2016 Q3 | 6.01 Billion USD | -5.12% |
| 2016 FY | 3.38 Billion USD | -15.35% |
| 2015 Q4 | 4 Billion USD | -23.42% |
| 2015 FY | 4 Billion USD | 5.76% |
| 2015 Q1 | 5.67 Billion USD | 50.11% |
| 2015 Q2 | 4.71 Billion USD | -16.98% |
| 2015 Q3 | 5.22 Billion USD | 10.82% |
| 2014 Q3 | 4.68 Billion USD | 23.53% |
| 2014 Q2 | 3.79 Billion USD | -33.48% |
| 2014 FY | 3.78 Billion USD | 22.55% |
| 2014 Q4 | 3.78 Billion USD | -19.33% |
| 2014 Q1 | 5.7 Billion USD | 84.87% |
| 2013 Q1 | 2.72 Billion USD | -71.79% |
| 2013 Q4 | 3.08 Billion USD | -42.64% |
| 2013 FY | 3.08 Billion USD | -68.1% |
| 2013 Q3 | 5.38 Billion USD | 127.77% |
| 2013 Q2 | 2.36 Billion USD | -13.45% |
| 2012 FY | 9.67 Billion USD | 12.46% |
| 2012 Q4 | 9.67 Billion USD | 16.8% |
| 2012 Q3 | 8.28 Billion USD | -24.94% |
| 2012 Q2 | 11.03 Billion USD | -10.3% |
| 2012 Q1 | 12.3 Billion USD | 43.01% |
| 2011 Q3 | 11.67 Billion USD | -17.47% |
| 2011 Q4 | 8.6 Billion USD | -26.3% |
| 2011 Q2 | 14.14 Billion USD | -11.84% |
| 2011 Q1 | 16.04 Billion USD | 5.06% |
| 2011 FY | 8.6 Billion USD | -43.67% |
| 2010 Q4 | 15.26 Billion USD | 2.49% |
| 2010 Q2 | 14.15 Billion USD | -10.16% |
| 2010 FY | 15.26 Billion USD | 99.7% |
| 2010 Q1 | 15.76 Billion USD | 106.11% |
| 2010 Q3 | 14.89 Billion USD | 5.22% |
| 2009 Q2 | 11.49 Billion USD | 6.09% |
| 2009 Q1 | 10.83 Billion USD | 47.81% |
| 2009 FY | 7.64 Billion USD | 4.27% |
| 2009 Q3 | 10.77 Billion USD | -6.27% |
| 2009 Q4 | 7.64 Billion USD | -29.06% |
| 2008 Q1 | 10.51 Billion USD | 7.74% |
| 2008 Q2 | 10.08 Billion USD | -4.02% |
| 2008 Q4 | 7.33 Billion USD | -14.24% |
| 2008 FY | 7.33 Billion USD | -24.84% |
| 2008 Q3 | 8.55 Billion USD | -15.24% |
| 2007 FY | 9.75 Billion USD | -17.93% |
| 2007 Q3 | 10.33 Billion USD | -4.23% |
| 2007 Q1 | 11.79 Billion USD | -0.8% |
| 2007 Q2 | 10.78 Billion USD | -8.53% |
| 2007 Q4 | 9.75 Billion USD | -5.56% |
| 2006 Q1 | 3.94 Billion USD | 5.61% |
| 2006 Q4 | 11.88 Billion USD | 33.31% |
| 2006 Q2 | 9.63 Billion USD | 143.97% |
| 2006 FY | 11.88 Billion USD | 217.92% |
| 2006 Q3 | 8.91 Billion USD | -7.44% |
| 2005 Q4 | 3.73 Billion USD | 0.07% |
| 2005 FY | 3.73 Billion USD | -32.68% |
| 2005 Q3 | 3.73 Billion USD | -12.88% |
| 2005 Q2 | 4.28 Billion USD | -21.61% |
| 2005 Q1 | 5.47 Billion USD | -1.48% |
| 2004 Q4 | 5.55 Billion USD | -3.74% |
| 2004 FY | 5.55 Billion USD | 11.22% |
| 2004 Q1 | 5.56 Billion USD | 11.34% |
| 2004 Q2 | 5.73 Billion USD | 3.14% |
| 2004 Q3 | 5.77 Billion USD | 0.62% |
| 2003 Q1 | 5.44 Billion USD | -4.71% |
| 2003 Q2 | 5.06 Billion USD | -7.04% |
| 2003 Q3 | 4.94 Billion USD | -2.37% |
| 2003 Q4 | 4.99 Billion USD | 0.99% |
| 2003 FY | 4.99 Billion USD | -12.65% |
| 2002 Q1 | 5.95 Billion USD | -10.19% |
| 2002 Q4 | 5.71 Billion USD | -7.69% |
| 2002 Q3 | 6.19 Billion USD | -1.83% |
| 2002 FY | 5.71 Billion USD | -13.77% |
| 2002 Q2 | 6.3 Billion USD | 5.95% |
| 2001 FY | 6.63 Billion USD | 933.57% |
| 2001 Q4 | 6.63 Billion USD | -0.43% |
| 2001 Q3 | 6.66 Billion USD | -3.31% |
| 2001 Q2 | 6.88 Billion USD | 5.15% |
| 2001 Q1 | 6.55 Billion USD | 921.04% |
| 2000 Q2 | 841.86 Million USD | -45.86% |
| 2000 FY | 641.6 Million USD | -60.52% |
| 2000 Q3 | 745.22 Million USD | -11.48% |
| 2000 Q4 | 641.6 Million USD | -13.9% |
| 2000 Q1 | 1.55 Billion USD | -4.31% |
| 1999 Q1 | 2.27 Billion USD | -18.5% |
| 1999 Q2 | 1.97 Billion USD | -13.17% |
| 1999 Q3 | 1.67 Billion USD | -15.02% |
| 1999 Q4 | 1.62 Billion USD | -3.17% |
| 1999 FY | 1.62 Billion USD | -41.77% |
| 1998 Q2 | 2.46 Billion USD | 11.81% |
| 1998 Q3 | 2.53 Billion USD | 2.94% |
| 1998 FY | 2.79 Billion USD | 12.1% |
| 1998 Q4 | 2.79 Billion USD | 9.98% |
| 1998 Q1 | 2.2 Billion USD | -11.43% |
| 1997 FY | 2.48 Billion USD | 12.82% |
| 1997 Q4 | 2.48 Billion USD | 1.69% |
| 1997 Q1 | 1.99 Billion USD | -9.4% |
| 1997 Q2 | 2.26 Billion USD | 13.42% |
| 1997 Q3 | 2.44 Billion USD | 7.96% |
| 1996 Q1 | 1.02 Billion USD | -15.18% |
| 1996 Q3 | 1.99 Billion USD | 0.07% |
| 1996 Q2 | 1.99 Billion USD | 95.12% |
| 1996 Q4 | 2.2 Billion USD | 10.66% |
| 1996 FY | 2.2 Billion USD | 83.28% |
| 1995 Q1 | 984.88 Million USD | 28.02% |
| 1995 FY | 1.2 Billion USD | 56.48% |
| 1995 Q2 | 1.01 Billion USD | 2.64% |
| 1995 Q4 | 1.2 Billion USD | 14.47% |
| 1995 Q3 | 1.05 Billion USD | 4.03% |
| 1994 Q2 | 872.47 Million USD | 7.55% |
| 1994 Q1 | 811.22 Million USD | -4.53% |
| 1994 Q3 | 850.15 Million USD | -2.56% |
| 1994 Q4 | 769.32 Million USD | -9.51% |
| 1994 FY | 769.32 Million USD | -9.47% |
| 1993 Q1 | 929.5 Million USD | 2.18% |
| 1993 Q2 | 1.08 Billion USD | 16.44% |
| 1993 Q3 | 942.1 Million USD | -12.95% |
| 1993 Q4 | 849.75 Million USD | -9.8% |
| 1993 FY | 849.75 Million USD | -6.59% |
| 1992 Q3 | 925.4 Million USD | 54.1% |
| 1992 Q1 | 772.8 Million USD | 26.9% |
| 1992 Q2 | 600.5 Million USD | -22.3% |
| 1992 Q4 | 909.7 Million USD | -1.7% |
| 1992 FY | 909.7 Million USD | 49.38% |
| 1991 Q1 | 661.5 Million USD | -13.48% |
| 1991 Q3 | 615.7 Million USD | -6.97% |
| 1991 Q4 | 609 Million USD | -1.09% |
| 1991 FY | 609 Million USD | -20.35% |
| 1991 Q2 | 661.8 Million USD | 0.05% |
| 1990 Q1 | 608.8 Million USD | 40.41% |
| 1990 Q3 | 954.6 Million USD | 12.66% |
| 1990 Q2 | 847.3 Million USD | 39.18% |
| 1990 FY | 764.6 Million USD | 76.34% |
| 1990 Q4 | 764.6 Million USD | -19.9% |
| 1989 Q4 | 433.6 Million USD | 0.0% |
| 1989 FY | 433.6 Million USD | 66.77% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Allurion Technologies Inc. | 3.82 Million USD | -234900.0% |
| Artivion, Inc. | 300.4 Million USD | -2888.339% |
| Avanos Medical, Inc. | 121.4 Million USD | -7294.563% |
| Butterfly Network, Inc. | -109.6 Million USD | 8290.021% |
| Butterfly Network, Inc. | -109.6 Million USD | 8290.021% |
| Bio-Rad Laboratories, Inc. | 1 Billion USD | -795.972% |
| Boston Scientific Corporation | 8.62 Billion USD | -4.057% |
| CONMED Corporation | 966.95 Million USD | -828.375% |
| Edwards Lifesciences Corporation | -449.1 Million USD | 2098.887% |
| Paragon 28, Inc. | 36.39 Million USD | -24568.187% |
| Glaukos Corporation | 290.27 Million USD | -2992.627% |
| Globus Medical, Inc. | 53.11 Million USD | -16802.018% |
| Inspire Medical Systems, Inc. | -160.69 Million USD | 5686.498% |
| Integer Holdings Corporation | 1.01 Billion USD | -782.45% |
| Medtronic plc | 24.76 Billion USD | 63.748% |
| Myomo, Inc. | -6.27 Million USD | 143273.775% |
| Nevro Corp. | 117.61 Million USD | -7532.854% |
| Owlet, Inc. | -1.34 Million USD | 669526.301% |
| Penumbra, Inc. | 66.85 Million USD | -13327.165% |
| Vicarious Surgical Inc. | -37.99 Million USD | 23729.903% |
| Smith & Nephew plc | 2.78 Billion USD | -222.682% |
| Sonendo, Inc. | 26.34 Million USD | -33978.658% |
| STERIS plc | 3.17 Billion USD | -182.638% |
| Stryker Corporation | 10.02 Billion USD | 10.445% |
| Vapotherm, Inc. | 102.66 Million USD | -8643.803% |
| Zimmer Biomet Holdings, Inc. | 5.57 Billion USD | -60.895% |